GlassScriptPhysician profile
Andrew Mccormick Cook
NPI 1992267322
$1,371.78
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $512 · 2022: $523 · 2023: $257 · 2024: $79.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $336.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $256.28 | 2021-2023 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $205.31 | 2021-2022 | |
| Glaxosmithkline, LLC. | $197.53 | 2021-2023 | Shingrix, Arexvy |
| Abbvie INC. | $188.89 | 2022-2024 | |
| Lilly USA, LLC | $165.80 | 2021-2023 | Emgality, Jardiance |
| E.R. Squibb & Sons, L.L.C. | $104.97 | 2022-2023 | Eliquis |
| Amgen INC. | $75.77 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.08 | 2021-2022 | |
| Pfizer INC. | $46.99 | 2021-2023 | |
| Cumberland Pharmaceuticals, INC. | $23.88 | 2021 | |
| Merck Sharp & Dohme LLC | $22.22 | 2021 | |
| Abbott Laboratories | $22.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.